Membrane News and Research

RSS

Ultrasound could help reduce the use of drugs for patients with rheumatoid arthritis

A research group led by the physician Christian Dejaco is investigating circumstances under which patients may stop taking medication for rheumatoid arthritis without running the risk of the disease flaring up again.

20 Jan 2020

Researchers visualize molecular organization of TNFα receptor molecules

Whether a sick cell dies, divides, or travels through the body is regulated by a sophisticat-ed interplay of signal molecules and receptors on the cell membrane.

17 Jan 2020

Study shows how extracellular vesicles help melanoma cells to spread

A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete.

16 Jan 2020

'Methylation clock' gene found to have functional role in aging of the eye

A lengthy-named gene called Elongation of Very Long Chain Fatty Acids Protein 2 or ELOVL2 is an established biomarker of age.

16 Jan 2020

Unique tool to democratize entry into the field of nanopore research

A nanopore is a tiny hole in a thin membrane with a diameter of around a billionth of a meter, or about the width of a single DNA molecule.

14 Jan 2020

Study shows superior functionality of Duodenum Intestine-Chip populated with organoids

Emulate, Inc. announced today a published study in collaboration with Johns Hopkins University School of Medicine, that demonstrated superior functionality of the Duodenum Intestine-Chip populated with organoids, compared to organoids alone.

14 Jan 2020

Scientists gain insights into structure and interactions of EGF receptors

Whether a cell grows, divides or dies is controlled among other things by receptors that messenger substances bind to externally.

13 Jan 2020

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against P2X7, a structurally complex ion channel that is the target for autoimmune disorders including atopic dermatitis and glomerulonephritis.

10 Jan 2020

Sodium chloride nanoparticles offer potential for cancer therapies with fewer side effects

A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient. Sodium chloride nanoparticles – more commonly known as salt – are toxic to cancer cells and offer the potential for therapies that have fewer negative side effects than current treatments.

9 Jan 2020

Researchers develop 'flash and freeze' method for studying nerve connections

Uniting structure and function of synapses is challenging: Function is studied in living tissue, measuring electrical signals at millisecond precision with electrophysiology, while the observation of fine structure at nanometer scale requires tissue to be fixed for electron microscopy.

9 Jan 2020

Administering enzalutamide results in significant increase in PSMA density on tumor surface

When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewhat remote, rather idealistic genius sitting alone in their room or laboratory and somehow discovering the most amazing things without every having contact with the 'normal' world.

9 Jan 2020

Discovery of cellular 'hands' could have implications in the fields of cell, developmental biology

The protein, called syndecan-4, combines with fellow cell membrane proteins, called integrins, to form protruding 'hands' that sense the environment outside the cell.

6 Jan 2020

Researchers reveal how antibodies assemble to form a circle for defensive attack

Antibodies are key players in our immune system. These antibodies recognize antigens displayed on foreign cell membranes and thereby recruit attacking forces, called complements.

6 Jan 2020

Study provides better understanding of mechanisms that limit cilia number in cells

One of the wonders of cell biology is its symmetry. Mammalian cells have one nucleus and one cell membrane, and most humans have 23 pairs of chromosomes.

30 Dec 2019

Certain bacteria can override programmed cell death

Certain bacteria can override a defense mechanism of the immune system, so called programmed cell death, through inhibition of death effector molecules by their outer membranes components.

26 Dec 2019

Ancestral-sequence reconstruction of FMO genes unveils structure of important enzyme

To disarm toxic substances, many organisms - including humans - possess enzymes called flavin-containing monooxygenases. Despite their importance, the structure of the enzymes has not been resolved, as the protein is too unstable to study in detail.

23 Dec 2019

Research findings may one day help keep ALS at bay

A new study published in the journal Nature Medicine on December 23, 2019, shows how to silence a defective gene responsible for the degeneration of the motor neurons in Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), in adult mice. This could help prevent disease progression if the condition is already symptomatic, and even suppress the illness if it has not yet started.

23 Dec 2019

Scientists unveil how Zika virus replicates

The World Health Organization (WHO) declared the Zika virus infection a global threat during the peak of its outbreak in 2016. Since then, scientists and health experts raced to understand the virus better to develop novel and effective vaccines and treatments for the disease. Now, a team of researchers in China revealed how a protein in the virus reshapes its host to boost viral replication.

23 Dec 2019

Texas law highlights dilemma over care for patients with no hope of survival

Critically ill Tinslee Lewis - a Fort Worth baby embroiled in a dispute between her family and a hospital over whether to continue life-sustaining treatment - is the most recent public face of the heartbreaking and intractable dilemmas often confronted quietly in intensive care units.

23 Dec 2019

Inhibition of a single enzyme may reduce heparin-induced thrombocytopenia

Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet in Munich have now shown that inhibition of a single enzyme may markedly reduce this risk.

21 Dec 2019

Membrane News and Research

Ultrasound could help reduce the use of drugs for patients with rheumatoid arthritis

Researchers visualize molecular organization of TNFα receptor molecules

Study shows how extracellular vesicles help melanoma cells to spread

'Methylation clock' gene found to have functional role in aging of the eye

Unique tool to democratize entry into the field of nanopore research

Study shows superior functionality of Duodenum Intestine-Chip populated with organoids

Scientists gain insights into structure and interactions of EGF receptors

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Sodium chloride nanoparticles offer potential for cancer therapies with fewer side effects

Researchers develop 'flash and freeze' method for studying nerve connections

Administering enzalutamide results in significant increase in PSMA density on tumor surface

Discovery of cellular 'hands' could have implications in the fields of cell, developmental biology

Researchers reveal how antibodies assemble to form a circle for defensive attack

Study provides better understanding of mechanisms that limit cilia number in cells

Certain bacteria can override programmed cell death

Ancestral-sequence reconstruction of FMO genes unveils structure of important enzyme

Research findings may one day help keep ALS at bay

Scientists unveil how Zika virus replicates

Texas law highlights dilemma over care for patients with no hope of survival

Inhibition of a single enzyme may reduce heparin-induced thrombocytopenia

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo